Equitable Access to High-Cost Pharmaceuticals - read free eBook in online reader or directly download on the web page. Select files or add your book in reader. Download and read online ebook Equitable Access to High-Cost Pharmaceuticals write by Zaheer-Ud-Din Babar. This book was released on 2018-02-27. Equitable Access to High-Cost Pharmaceuticals available in PDF, EPUB and Kindle. Equitable Access to High-Cost Pharmaceuticals seeks to aid the development and implementation of equitable public health policies by pharmaco-economics professionals, health economists, and policymakers. With detailed country-by country analysis of policy and regulation, the Work compares and contrasts national healthcare systems to support researchers and practitioners identify optimal healthcare policy solutions. The Work incorporates chapters on global regulatory changes, health technology assessment guidelines, and competitive effectiveness research recommendations from international bodies such as the OECD or the EU. Novel policies such as horizon scanning, managed-entry agreement and post-launch monitoring are considered in detail. The Work also thoroughly reviews novel pharmaceuticals with particular research interest, including cancer drugs, orphan medicines, Hep C, and personalized medicines. Evaluates impact and efficacy of current access policies and pricing regulation of high-cost drugs Incorporates existing guidelines and recommendations by international organizations Compares and contrasts how different countries fund and police high-cost drug access Explores novel and emergent policies, including managed entry agreement, analysis of real world data and differential pricing Reviews novel pharmaceuticals of current research interest
Making Medicines Affordable
Making Medicines Affordable - read free eBook in online reader or directly download on the web page. Select files or add your book in reader. Download and read online ebook Making Medicines Affordable write by National Academies of Sciences, Engineering, and Medicine. This book was released on 2018-03-01. Making Medicines Affordable available in PDF, EPUB and Kindle. Thanks to remarkable advances in modern health care attributable to science, engineering, and medicine, it is now possible to cure or manage illnesses that were long deemed untreatable. At the same time, however, the United States is facing the vexing challenge of a seemingly uncontrolled rise in the cost of health care. Total medical expenditures are rapidly approaching 20 percent of the gross domestic product and are crowding out other priorities of national importance. The use of increasingly expensive prescription drugs is a significant part of this problem, making the cost of biopharmaceuticals a serious national concern with broad political implications. Especially with the highly visible and very large price increases for prescription drugs that have occurred in recent years, finding a way to make prescription medicinesâ€"and health care at largeâ€"more affordable for everyone has become a socioeconomic imperative. Affordability is a complex function of factors, including not just the prices of the drugs themselves, but also the details of an individual's insurance coverage and the number of medical conditions that an individual or family confronts. Therefore, any solution to the affordability issue will require considering all of these factors together. The current high and increasing costs of prescription drugsâ€"coupled with the broader trends in overall health care costsâ€"is unsustainable to society as a whole. Making Medicines Affordable examines patient access to affordable and effective therapies, with emphasis on drug pricing, inflation in the cost of drugs, and insurance design. This report explores structural and policy factors influencing drug pricing, drug access programs, the emerging role of comparative effectiveness assessments in payment policies, changing finances of medical practice with regard to drug costs and reimbursement, and measures to prevent drug shortages and foster continued innovation in drug development. It makes recommendations for policy actions that could address drug price trends, improve patient access to affordable and effective treatments, and encourage innovations that address significant needs in health care.
WHO guideline on country pharmaceutical pricing policies
WHO guideline on country pharmaceutical pricing policies - read free eBook in online reader or directly download on the web page. Select files or add your book in reader. Download and read online ebook WHO guideline on country pharmaceutical pricing policies write by . This book was released on 2020-09-29. WHO guideline on country pharmaceutical pricing policies available in PDF, EPUB and Kindle. In recent years, high prices of pharmaceutical products have posed challenges in high- and low-income countries alike. In many instances, high prices of pharmaceutical products have led to significant financial hardship for individuals and negatively impacted on healthcare systems' ability to provide population-wide access to essential medicines. Pharmaceutical pricing policies need to be carefully planned, carried out, and regularly checked and revised according to changing conditions. Strong, well-thought-out policies can guide well-informed and balanced decisions to achieve affordable access to essential health products. This guideline replaces the 2015 WHO guideline on country pharmaceutical pricing policies, revised to reflect the growing body of literature since the last evidence review in 2010. This update also recognizes country experiences in managing the prices of pharmaceutical products.
The Role of NIH in Drug Development Innovation and Its Impact on Patient Access
The Role of NIH in Drug Development Innovation and Its Impact on Patient Access - read free eBook in online reader or directly download on the web page. Select files or add your book in reader. Download and read online ebook The Role of NIH in Drug Development Innovation and Its Impact on Patient Access write by National Academies of Sciences, Engineering, and Medicine. This book was released on 2020-01-27. The Role of NIH in Drug Development Innovation and Its Impact on Patient Access available in PDF, EPUB and Kindle. To explore the role of the National Institutes of Health (NIH) in innovative drug development and its impact on patient access, the Board on Health Care Services and the Board on Health Sciences Policy of the National Academies jointly hosted a public workshop on July 24â€"25, 2019, in Washington, DC. Workshop speakers and participants discussed the ways in which federal investments in biomedical research are translated into innovative therapies and considered approaches to ensure that the public has affordable access to the resulting new drugs. This publication summarizes the presentations and discussions from the workshop.
Towards a New Vision for Shared Responsibility in Pharmaceutical Pricing, Coverage and Reimbursement
Towards a New Vision for Shared Responsibility in Pharmaceutical Pricing, Coverage and Reimbursement - read free eBook in online reader or directly download on the web page. Select files or add your book in reader. Download and read online ebook Towards a New Vision for Shared Responsibility in Pharmaceutical Pricing, Coverage and Reimbursement write by Elizabeth Docteur. This book was released on 2022. Towards a New Vision for Shared Responsibility in Pharmaceutical Pricing, Coverage and Reimbursement available in PDF, EPUB and Kindle. Concerns about affordable access to medicines reflect the emergence of new, high-priced medicines, as well as expectations regarding the cost of precision therapies coming to market. Compared with a decade ago, novel medicines are subject to longer delays between global launch and market access, even in wealthier countries. Various paths forward offer potential policy solutions to address problems with access to high-priced pharmaceuticals. This technical report considers four categories of policies - demand pooling, formal tiered pricing, risk-sharing agreements and policies to harness competition - with potential to ameliorate issues in ensuring timely, affordable and equitable access to effective medicines in the WHO European Region. Each approach offers the potential to address a different dimension of the affordability problem. The most promising strategies to tackle affordability of high-priced medicines are likely to entail a combination approach - for example, a test pilot of a single-buyer agreement using a combination of managed-entry agreements and tiered pricing for agreement signatories under an agreed formula. To facilitate policy development, stakeholder commitment to three underlying principles - solidarity, transparency and sustainability - is essential.
